Symbolic Representation in Young Children With Down Syndrome

University of Sao Paulo25 enrolled

Overview

The aim of this study is to characterize the process of constitution of symbolic representation in infants with Down syndrome, as well as to investigate the relationship between gestures and the emergence of oral language. The investigators hypothesis is that children with Down syndrome could present difficulties during the constitution of symbolic representation that may be related to later deficits on expressive language, generally observed in these children.

According to the Genetic Epistemology, language development is directly related to cognitive construction. Such relationship is clearly observed after the constitution of representation that allows one individual to express his or her thinking through language.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Down Syndrome

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria for Study Group: * genetic diagnosis of Down Syndrome * be at the 4th stage of sensorimotor period at the initial assessment * good health conditions * good results on audiologic evaluation * pediatric and ear, nose and throat periodic check ups. Inclusion Criteria for Control Group: * good health conditions * be at the 4th stage of sensorimotor period at the initial assessment * pediatric and ear, nose and throat periodic check ups. Exclusion Criteria for all groups: * submission to long term hospitalizations due to heart diseases and major respiratory airway infections, that may interfere in the child's global development * presence of visual or auditory important deficits * historic of prematurely and/or low birth weight

Locations (3)

APAE Sao José dos Campos

São José dos Campos, São Paulo, Brazil

University Hospital

São Paulo, São Paulo, Brazil

University of Sao Paulo - School of Medicine - Department of Physiotherapy, Communication Sciences and Disorders, Occupational Therapy

São Paulo, São Paulo, Brazil

Outcomes

Primary Outcomes

Performance on monthly assessments administered after the initial evaluation

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.